Home LiteratureArticle Details
PMID: 15197276 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease.

Benner EJ, Mosley RL, Destache CJ, Lewis TB, Jackson-Lewis V, Gorantla S, Nemachek C, Green SR, Przedborski S, Gendelman HE

Abstract

Degeneration of the nigrostriatal dopaminergic pathway, the hallmark of Parkinson's disease, can be recapitulated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice. Herein, we demonstrate that adoptive transfer of copolymer-1 immune cells to MPTP recipient mice leads to T cell accumulation within the substantia nigra pars compacta, suppression of microglial activation, and increased local expression of astrocyte-associated glial cell line-derived neurotrophic factor. This immunization strategy resulted in significant protection of nigrostriatal neurons against MPTP-induced neurodegeneration that was abrogated by depletion of donor T cells. Such vaccine treatment strategies may provide benefit for Parkinson's disease.

MeSH Terms
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Adoptive Transfer Animals Coat Protein Complex I/immunology Corpus Striatum/immunology,pathology Cytokines/analysis Disease Models, Animal Dopamine/immunology Immunohistochemistry Mesencephalon/immunology,pathology Mice Mycobacterium tuberculosis/immunology Neurons/immunology,pathology Ovalbumin/immunology Parkinsonian Disorders/chemically induced,immunology,pathology Reverse Transcriptase Polymerase Chain Reaction Substantia Nigra/immunology,pathology Transcription, Genetic
Chemicals
Coat Protein Complex I Cytokines Ovalbumin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Dopamine
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Benner Eric J
Center for Neurovirology and Neurodegenerative Disorders and Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, 68198, USA.
Mosley R Lee
Destache Chris J
Lewis Travis B
Jackson-Lewis Vernice
Gorantla Santhi
Nemachek Craig
Green Steven R
Przedborski Serge
Gendelman Howard E
References (40)
40 references, click to expand
  1. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease.
    J Clin Invest. 2003 Sep;112(6):892-901 PMID: 12975474
  2. Parkinson's disease: mechanisms and models.
    Neuron. 2003 Sep 11;39(6):889-909 PMID: 12971891
  3. TGFbeta directs gene expression of activated microglia to an anti-inflammatory phenotype strongly focusing on chemokine genes and cell migratory genes.
    Glia. 2003 Dec;44(3):219-31 PMID: 14603463
  4. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.
    Nature. 1984 Oct 4-10;311(5985):464-7 PMID: 6332988
  5. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.
    Neurology. 1988 Aug;38(8):1285-91 PMID: 3399080
  6. Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes.
    J Neurosci Res. 1993 Apr 1;34(5):539-45 PMID: 8478988
  7. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Exp Neurol. 1994 Apr;126(2):195-204 PMID: 7925820
  8. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
    J Pharmacol Exp Ther. 1994 Sep;270(3):1008-14 PMID: 7932148
  9. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Neurodegeneration. 1995 Sep;4(3):257-69 PMID: 8581558
  10. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10821-6 PMID: 9380718
  11. Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion.
    J Neuroimmunol. 1998 Jan;81(1-2):20-30 PMID: 9521602
  12. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration.
    J Neurosci. 1998 Aug 1;18(15):5804-16 PMID: 9671668
  13. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy.
    Nat Med. 1999 Jan;5(1):49-55 PMID: 9883839
  14. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?
    J Exp Med. 1999 Mar 1;189(5):865-70 PMID: 10049950
  15. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia.
    J Neurochem. 1999 Apr;72(4):1466-71 PMID: 10098850
  16. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.
    Exp Neurol. 1999 Mar;156(1):50-61 PMID: 10192776
  17. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors.
    J Immunol. 1999 Jun 1;162(11):6303-6 PMID: 10352239
  18. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity.
    J Autoimmun. 2000 Nov;15(3):331-45 PMID: 11040074
  19. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
    Nat Med. 1999 Dec;5(12):1403-9 PMID: 10581083
  20. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies.
    Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7446-51 PMID: 10861010
  21. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells.
    J Neurosci. 2000 Jul 15;20(14):5283-91 PMID: 10884312
  22. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.
    J Neurosci. 2000 Sep 1;20(17):6421-30 PMID: 10964948
  23. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice.
    J Neurosci Res. 2000 Oct 15;62(2):273-8 PMID: 11020219
  24. Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1.
    Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11472-7 PMID: 11027347
  25. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.
    Science. 2000 Oct 27;290(5492):767-73 PMID: 11052933
  26. IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia.
    J Immunol. 2000 Dec 1;165(11):6235-43 PMID: 11086058
  27. Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.
    J Neurosci. 2001 Jan 1;21(1):136-42 PMID: 11150329
  28. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.
    J Neurochem. 2001 Mar;76(5):1265-74 PMID: 11238711
  29. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.
    Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3398-403 PMID: 11248090
  30. Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS.
    Mult Scler. 2001 Aug;7(4):209-19 PMID: 11548979
  31. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.
    J Neurosci. 2002 Mar 1;22(5):1763-71 PMID: 11880505
  32. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity.
    FASEB J. 2002 Aug;16(10):1304-6 PMID: 12154003
  33. Severe immunodeficiency has opposite effects on neuronal survival in glutamate-susceptible and -resistant mice: adverse effect of B cells.
    J Immunol. 2002 Sep 15;169(6):2861-5 PMID: 12218098
  34. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lipid peroxidation and DNA damage in mouse bone marrow and blood.
    Environ Mol Mutagen. 2003;41(1):64-8 PMID: 12552593
  35. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
    Nat Med. 2003 May;9(5):589-95 PMID: 12669033
  36. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2003 May 13;100(10):6145-50 PMID: 12721370
  37. Novel anti-inflammatory therapy for Parkinson's disease.
    Trends Pharmacol Sci. 2003 Aug;24(8):395-401 PMID: 12915048
  38. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.
    Arch Neurol. 2003 Aug;60(8):1059-64 PMID: 12925360
  39. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.
    J Neurosci. 2003 Aug 27;23(21):7922-30 PMID: 12944523
  40. Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor.
    J Neurol Sci. 2003 Nov 15;215(1-2):37-44 PMID: 14568126
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2004-06-22
Epub
2004-00-14
Pages
9435-40
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC438994
Subset
IM
Grants
NINDS NIH HHS · R01 NS38586 · United States
NIA NIH HHS · R01 AG021617 · United States
NINDS NIH HHS · P50 NS038370 · United States
NINDS NIH HHS · P50 NS 38370 · United States
NINDS NIH HHS · 1T32 NS07488 · United States
NIMH NIH HHS · P01 MH64570 · United States
NCRR NIH HHS · P20RR15635 · United States
NIMH NIH HHS · P01 MH064570 · United States
NINDS NIH HHS · R01 NS 42269 · United States
NINDS NIH HHS · R37 NS036126 · United States
NINDS NIH HHS · P01 NS011766 · United States
NINDS NIH HHS · T32 NS007488 · United States
NCRR NIH HHS · P20 RR015635 · United States
NINDS NIH HHS · R01 NS042269 · United States
NINDS NIH HHS · R01 NS038586 · United States
NINDS NIH HHS · 2R37 NS36126 · United States
NINDS NIH HHS · P01 NS11766 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com